Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AArtiva Biotherapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Artiva Biotherapeutics, Inc.

$7.05Close · Oct 7, 2026
  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

Compare sales with the profit left after direct costs and the profit left after all expenses and taxes.Formula: Gross profit = revenue − cost of revenue Net income = total income − total expenses
Q4 ’24202320242026-10M010M20MLatest period Q4 '24. Revenue 0. Gross profit 0. Net profit -16.1M.
RevenueGross profitNet profit
See how much of each dollar of sales remains after direct costs, after running the business, and after all expenses and taxes.Formula: Gross margin = gross profit ÷ revenue × 100% Operating margin = operating income ÷ revenue × 100% Net margin = net income ÷ revenue × 100%
Q4 ’24202320242026-4,000%-2,000%0%Latest period Q4 '24. No revenue — margins undefined.
Gross marginOperating marginNet profit marginNo revenue (margins undefined)
Compare cash generated by the business, spending on long-lived assets, and what remains afterward.Formula: Free cash flow = operating cash flow − capital expenditures
$
Q2 ’262023202420252026-20M-15M-10M-5M0
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    • Capex: purchases of property, plant and equipment
    Latest period Q2 '26. Operating cash flow -20.4M. Capex -415K. Free cash flow -20.8M.
    Operating cash flowCapexFree cash flow
    Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
    202620232024202520260100M200M300M
        Latest period 2026. Cash 301.5M. Debt 0.
        CashDebtNet cash
        Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
        $/shareUsing split history cached 2026-10-07; assuming no new splits
        four_consecutive_quarters_unavailableMissingfour_consecutive_quarters_unavailableMissingQ2 ’262023202420252026-40.00-30.00-20.00-10.000.00
        • Q2 2023: four consecutive quarters unavailable
        • Q3 2023: four consecutive quarters unavailable
        • Earnings period 2023-04-01 to 2023-06-30. Shares as of 2023-06-30: unavailable source shares.
        • Earnings period 2023-07-01 to 2023-09-30. Shares as of 2023-09-30: unavailable source shares.
        • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 809,758 source shares.
        • Earnings period 2024-01-01 to 2024-03-31. Shares as of 2025-04-30: 24,363,119 source shares. Uses later-dated shares from the same quarterly filing.
        • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-06-30: 814,202 source shares.
        • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-09-30: 24,287,144 source shares.
        • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 24,291,607 source shares.
        • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2025-03-31: 24,363,119 source shares.
        • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: 24,393,524 source shares.
        • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-09-30: 24,544,904 source shares.
        • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 24,595,550 source shares.
        • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-03-31: 24,716,672 source shares.
        • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: 48,792,279 source shares.
        Latest period Q2 2026. EPS (TTM) -1.86.
        EPS (TTM)
        How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
        Using split history cached 2026-10-07; assuming no new splits
        four consecutive quarters unavailableMissingfour consecutive quarters unavailableMissinghistorical price missing or staleMissinghistorical price missing or staleMissingQ2 ’262023202420252026-6x-4x-2x0x
        • Q2 2023: four consecutive quarters unavailable
        • Q3 2023: four consecutive quarters unavailable
        • FY 2023: historical price missing or stale
        • Q2 2024: historical price missing or stale
        • Earnings period 2023-04-01 to 2023-06-30. Shares as of 2023-06-30: unavailable source shares.
        • Earnings period 2023-07-01 to 2023-09-30. Shares as of 2023-09-30: unavailable source shares.
        • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 809,758 source shares.
        • Earnings period 2024-01-01 to 2024-03-31. Shares as of 2025-04-30: 24,363,119 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2025-05-02.
        • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-06-30: 814,202 source shares.
        • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-09-30: 24,287,144 source shares. Nearby weekly price on 2024-09-27.
        • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 24,291,607 source shares. Nearby weekly price on 2025-01-03.
        • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2025-03-31: 24,363,119 source shares. Nearby weekly price on 2025-03-28.
        • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: 24,393,524 source shares. Nearby weekly price on 2025-06-27.
        • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-09-30: 24,544,904 source shares. Nearby weekly price on 2025-10-03.
        • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 24,595,550 source shares. Nearby weekly price on 2026-01-02.
        • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-03-31: 24,716,672 source shares. Nearby weekly price on 2026-04-02.
        • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: 48,792,279 source shares. Nearby weekly price on 2026-07-02.
        Latest period Q2 2026. P/E ratio -5.2x.
        P/E ratio
        See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
        Stock split history may be out of date.
        20262023202420252026010M20M30M40M
            Latest period 2026. Shares outstanding 48.8M. Class detail unavailable 48.8M.
            Class detail unavailable